Safety
HD11 XE Getting Started
4535 612 62651
2
54
•Whenever latex-containing medical devices are used, especially when
the latex comes in contact with mucous membranes, be alert to the
possibility of an allergic reaction.
• If an allergic reaction does occur and latex is suspected, advise the
patient of a possible latex sensitivity and consider an immunologic
evaluation.
•Advise the patient to tell health professionals and emergency person-
nel about any known latex sensitivity before undergoing medical pro-
cedures. Consider advising patients with severe latex sensitivity to
wear a medical identification bracelet.
The FDA is asking health professionals to report incidents of adverse reac-
tions to latex or other materials used in medical devices. (See the October
1990 FDA Drug Bulletin.) To report an incident, call the FDA Problem
Reporting Program, operated through the U.S. Pharmacopeia toll-free num-
ber: 800-638-6725. (In Maryland, call collect 301-881-0256.)
For a single copy of a reference list on latex sensitivity, write to: LATEX DA,
HFZ-220, Rockville, MD 20857.
Tr a n s m i s s i b l e S p o n g i f o r m E n c e p h a l o p a t h y
WARNING
If a sterile transducer cover becomes compromised during an intraoperative
application involving a patient with transmissible spongiform encephalopathy, such
as Creutzfeldt-Jakob disease, follow the guidelines of the Centers for Disease
Control and Prevention (CDC) and the World Heath Organization (WHO). The
WHO provides infection control guidelines for transmissible spongiform enceph-
alopathies. The transducers for your system cannot be decontaminated using a
heat process.
To Next Page
Loading...